Difficulty: Medium
Average Score: 77%
Practice
The first-line therapy of atopic dermatitis (AD) is
Correct answer
A
Rationale
Atopic dermatitis (AD) is a common chronic inflammatory skin condition in children. The first-line therapy for AD is moisturizers (Option A) because they help to repair the skin barrier, prevent water loss, and reduce itching and inflammation. Moisturizers are essential in managing AD as they hydrate the skin and improve its function, which is crucial in minimizing flare-ups and maintaining skin health.
Option B, cyclosporine, is not typically used as a first-line therapy for AD in children due to its potential serious side effects and the availability of safer treatment options like topical steroids and moisturizers. Cyclosporine is usually reserved for severe cases that do not respond to other treatments.
Antihistamines (Option C) are used to manage itching in AD but are not the first-line therapy. They may provide symptomatic relief but do not address the underlying cause of AD, which is a defective skin barrier.
Tar preparations (Option D) are not recommended as first-line therapy for pediatric AD due to their strong odor, messy application, and potential side effects such as skin irritation and staining of clothes. They are considered in cases where other treatments have failed due to their potential efficacy in reducing inflammation and itching.
In an educational context, understanding the rationale behind the first-line therapy for AD is crucial for pediatric nurses to provide effective care. By knowing that moisturizers are the cornerstone of AD management, nurses can educate patients and families on proper skincare techniques, reinforce the importance of consistent moisturization, and empower them to take an active role in managing the condition. This knowledge ensures holistic care and better outcomes for pediatric patients with AD.
Option B, cyclosporine, is not typically used as a first-line therapy for AD in children due to its potential serious side effects and the availability of safer treatment options like topical steroids and moisturizers. Cyclosporine is usually reserved for severe cases that do not respond to other treatments.
Antihistamines (Option C) are used to manage itching in AD but are not the first-line therapy. They may provide symptomatic relief but do not address the underlying cause of AD, which is a defective skin barrier.
Tar preparations (Option D) are not recommended as first-line therapy for pediatric AD due to their strong odor, messy application, and potential side effects such as skin irritation and staining of clothes. They are considered in cases where other treatments have failed due to their potential efficacy in reducing inflammation and itching.
In an educational context, understanding the rationale behind the first-line therapy for AD is crucial for pediatric nurses to provide effective care. By knowing that moisturizers are the cornerstone of AD management, nurses can educate patients and families on proper skincare techniques, reinforce the importance of consistent moisturization, and empower them to take an active role in managing the condition. This knowledge ensures holistic care and better outcomes for pediatric patients with AD.